Originally approved to help with excess weight and obesity, Wegovy and Ozempic, have become synonymous with weight loss fads. Here's what you need to know.
These new challengers are anticipated to account for roughly $70 billion of the total GLP-1 market, which is expected to be worth $200 billion by 2031. Our report on the obesity drug market ...
Some results have been hidden because they may be inaccessible to you